DiaSorin consensus shifts after mixed analyst views, shares on Milan radar

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 16:31.

DiaSorin (IT0003497168) stands out on Borsa Italiana as analyst opinions diverge between a recent downgrade by Deutsche Bank and a fresh price target increase by RBC, shaping a nuanced consensus picture alongside diagnostics peer Qiagen.

What recent analysts are saying

On 17 June 2026, Deutsche Bank downgraded DiaSorin shares from Hold to Sell and lowered its price target, citing a cautious view on growth versus valuation according to a MarketScreener summary of the Deutsche Bank note.

Just days later, on 22 June 2026, RBC Capital Markets reiterated its Outperform rating on DiaSorin and raised its price target, signaling confidence in the company’s diagnostics franchise despite the earlier downgrade, as reported in a recent MarketScreener news item on the RBC decision.

How the consensus stacks up

The split between Deutsche Bank’s Sell stance and RBC’s Outperform rating feeds into a broader consensus in which DiaSorin collects a mix of Buy, Hold and Sell recommendations on MarketScreener, with an average target price that implies limited upside from current Milan levels as of late June 2026 according to the MarketScreener analyst consensus overview.

Against this backdrop, investors also compare DiaSorin with international diagnostics names such as Qiagen, which trades in Frankfurt and on the NYSE, when assessing growth profiles and valuation multiples within the sector based on European broker commentary collated by MarketScreener.

The diagnostics business behind DiaSorin

DiaSorin generates its revenue primarily from in vitro diagnostics, with a focus on immunodiagnostic and molecular testing platforms used in hospital and laboratory settings worldwide; one representative product is its molecular assays portfolio for infectious disease testing, described in the group’s official investor information.

Where the DiaSorin shares trade today

The DiaSorin shares (IT0003497168) last traded on Borsa Italiana in Milan at 99.90 euros on 2026-06-23, 15:55, according to recent quote data compiled by MarketScreener.

This text is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any financial instrument. All data are based on sources deemed reliable, but accuracy and completeness cannot be guaranteed.